Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning

Journal of Physiology and Pharmacology

Volumn 53, Issue 3, 2002, Pages 371-382

  Beresewicz, A ^a   Dobrzyn, A ^b   Gorski, J ^b  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ceramide; Ischemia reperfusion; Ischemia reperfusion injury; Ischemic preconditioning; Isolated rat heart

Indexed keywords

15 TETRACOSENOIC ACID; ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; CERAMIDE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BIOCHEMISTRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GAS LIQUID CHROMATOGRAPHY; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMIC MONITORING; HYPOTHESIS; LIPID ANALYSIS; MALE; METHYLATION; NONHUMAN; PRODUCT RECOVERY; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CERAMIDES; FATTY ACIDS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, WISTAR; RECOVERY OF FUNCTION;

EID: 0036740846     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mathias S, Pena LA, Kolesnick RN. Signal transduction of stress via ceramide. Biochem J 1998; 335: 465-480.
2. Hannun YA, Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol 2000;10: 73-80.
3. Pfeilschifter J, Huwiler A. Ceramides as key players in cellular stress response. News Physiol Sci 2000; 15: 11-15.
4. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 2000; 349: 385-402.
5. Kubota M, Narita K, Nakagomi T, Tamura A, Shimasaki H, Ueta N, Yoshida S. Sphingomyelin changes in rat cerebral cortex during focal ischemia. Neurol Res 1996; 18: 337-341.
6. Zager RA, Iwata M, Conrad DS, Burkhart KM, Igarashi Y. Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int 1997; 52: 60-70.
7. Bielawska AE, Shapiro JP, Jiang L, Melkonyan HS, Piot C, Wolfe CL, Tomei LD, Hannun YA, Umansky SR. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol 1997; 151: 1257-1263.
8. Cordis GA, Yoshida T, Das DK. HPTLC analysis of sphingomylein, ceramide and sphingosine in ischemic/reperfused rat heart. J Pharm Biomed Anal 1998; 16: 1189-1193.
9. Zhang DX, Fryer RM, Hsu AK, Zou AP, Gross GJ, Campbell WB, Li PL. Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol 2001; 96: 267-274.
10. Cain BS, Harken AH, Meldrum DR. Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol 1999; 31: 931-947.
11. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998; 274: R577-R595.
12. Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, Mohr R, Yakirevich V. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 1996; 28: 247-252.
13. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98: 2854-2865.
14. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628.
15. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949-956.
16. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000; 45: 651-660.
17. Hernandez OM, Discher DJ, Bishopric NH, Webster KA. Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes. Circ Res 2000; 86: 198-204.
18. Zhang DX, Zou AP, Li PL. Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries. Circ Res 2001; 88: 824-831.
19. Zhang P, Liu B, Jenkins GM, Hannun YA, Obeid LM. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J Biol Chem 1997; 272: 9609-9612.
20. Dobrzyn A, Gorski J. The content and composition of ceramides and shingomyelins in skeletal muscles of the rat. Effect of prolonged exercise. Am J Physiol 2002; 202; E277-E285.
21. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
22. Przyklenk K, Kloner RA. Ischemic preconditioning: exploring the paradox. Prog Cardiovasc Dis 1998; 40: 517-547.
23. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to K-ATP channel. Annu Rev Physiol 2000; 62: 79-109.
24. Meldrum DR, Dinarello CA, Shames BD, Cleveland JC, Cain BS, Banerjee A, Meng XZ, Harken AH. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production: potential ultimate effector mechanism of preconditioning. Circulation 1998; 98: 11214-11218.
25. Gottlieb RA, Gruol DL, Zhu JY, Engler RL. Preconditioning in rabbit cardiomyocytes - role of ph, vacuolar proton ATPase, and apoptosis. J Clin Invest 1996; 97: 2391-2398.
26. Piot CA, Padmanaban D, Ursell PC, Sievers RE, Wolfe CL. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 1997; 96: 1598-1604.
27. Nakamura M, Wang NP, Zhao ZQ, Wilcox JN, Thourani V, Guyton RA, Vinten-Johansen J. Preconditioning decreases bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 2000; 45: 661-670.
28. Prevati M, Bertolaso L, Tramarin M, Bertaggnolo V, Capitani S. Low nanogram range quantitation of diglycerides and ceramide by high-perfirmance liquid chromarography. Anal Biochem 1996; 233: 108-114.
29. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964; 5: 600-608.
30. Murase K, Okumura K, Hayashi K, Matsui H, Toki Y, Ito T, Hayakawa T. Measurements of 1,2-diacylglycerol and ceramide in hearts subjected to ischemic preconditioning. Life Sci 2000; 66: 1491-1500.
31. Coroneos E, Martinez M, McKenna S, Kester M. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J Biol Chem 1995; 270: 23305-23309.
32. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994; 77: 325-328.
33. Nikolova-Karakashian M, Morgan ET, Alexander C, Liotta DC, Merrill AH, Jr. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. J Biol Chem 1997; 272: 18718-18724.
34. Feuerstein GZ, Young PR. Apoptosis in cardiac diseases: stress- and mitogen- activated signaling pathways. Cardiovasc Res 2000; 45: 560-569.
35. Freude B, Masters TN, Kostin S, Robicsek F, Schaper J. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol 1998; 93: 85-89.